We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+31.4%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.36B
AUM Growth
+$338M
(+33%)
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
6.93%
Top 10 Holdings %
Top 10 Hldgs %
21.23%
Holding
371
New
69
Increased
89
Reduced
146
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Barclays
BCS
|
+$17.9M |
| 2 |
KB Financial Group
KB
|
+$17M |
| 3 |
British American Tobacco
BTI
|
+$15.3M |
| 4 |
Cummins
CMI
|
+$12.4M |
| 5 |
Ecopetrol
EC
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$17.9M |
| 2 |
Home Depot
HD
|
+$14.8M |
| 3 |
Broadridge
BR
|
+$13.6M |
| 4 |
eBay
EBAY
|
+$10.7M |
| 5 |
Duke Energy
DUK
|
+$10.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.65% |
| 2 | Consumer Discretionary | 14.7% |
| 3 | Industrials | 11.15% |
| 4 | Energy | 10.43% |
| 5 | Technology | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Yeti Holdings
YETI
$3.82B
| $1.16M | 0.09% |
16,989
-6,705
| -28% | -$397K |
|
177
CRISPR Therapeutics
CRSP
$4.58B
| $1.14M | 0.08% |
7,444
-6,171
| -45% | -$729K |
|
178
Chesapeake Utilities
CPK
$3.26B
| $1.1M | 0.08% |
10,147
-71,681
| -88% | -$7.18M |
|
179
BlackRock TCP Capital
TCPC
$265M
| $1.1M | 0.08% |
97,663
-39,147
| -29% | -$424K |
|
180
Saia
SAIA
$11.3B
| $1.1M | 0.08% |
6,062
-4,307
| -42% | -$707K |
|
181
DraftKings
DKNG
$11.4B
| $1.08M | 0.08% |
23,266
-866
| -4% | -$41.2K |
|
182
SLR Investment Corp
SLRC
$706M
| $1.08M | 0.08% |
61,662
-36,889
| -37% | -$625K |
|
183
US Foods
USFD
$21.4B
| $1.08M | 0.08% |
32,430
+2,025
| +7% | +$57.8K |
|
184
Tesla
TSLA
$1.24T
| $1.07M | 0.08% |
4,530
-822
| -15% | -$140K |
|
185
TripAdvisor
TRIP
$1.59B
| $1.06M | 0.08% |
+36,793
| New | +$886K |
|
|
186
Home Depot
HD
$332B
| $1.06M | 0.08% |
3,978
-53,933
| -93% | -$14.8M |
|
|
TPTX
187
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.06M | 0.08% |
8,666
-2,173
| -20% | -$238K |
|
188
Darden Restaurants
DRI
$22.5B
| $1.05M | 0.08% |
8,846
+5,309
| +150% | +$569K |
|
|
EAR
189
DELISTED
Eargo, Inc. Common Stock
EAR
| $1.05M | 0.08% |
+1,176
| New | +$991K |
|
190
Vail Resorts
MTN
$5.19B
| $1.04M | 0.08% |
3,735
-190
| -5% | -$49.1K |
|
191
McDonald's
MCD
$188B
| $1.04M | 0.08% |
4,842
+1,922
| +66% | +$418K |
|
192
Gentherm
THRM
$1.31B
| $1.04M | 0.08% |
+15,879
| New | +$857K |
|
193
BridgeBio Pharma
BBIO
$16.5B
| $1M | 0.07% |
14,101
+4,334
| +44% | +$209K |
|
194
Verizon
VZ
$194B
| $987K | 0.07% |
16,800
-2,485
| -13% | -$148K |
|
195
Axalta
AXTA
$7.01B
| $981K | 0.07% |
34,365
-225
| -0.7% | -$6.13K |
|
196
Camping World
CWH
$363M
| $967K | 0.07% |
37,129
-15,057
| -29% | -$441K |
|
|
FSKR
197
DELISTED
FS KKR Capital Corp. II
FSKR
| $965K | 0.07% |
+58,813
| New | +$940K |
|
|
XLRN
198
DELISTED
Acceleron Pharma
XLRN
| $957K | 0.07% |
7,478
-2,017
| -21% | -$236K |
|
199
Castle Biosciences
CSTL
$749M
| $939K | 0.07% |
13,991
-6,457
| -32% | -$350K |
|
200
Moderna
MRNA
$21.5B
| $932K | 0.07% |
8,919
-5,956
| -40% | -$603K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q4 2020 Portfolio in Review
As of Q4 2020, Advisory Research held 371 positions worth $1.36B, up 33% from $1.03B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Advisory Research deployed $94.4M of net new capital in Q4 2020, opening 69 new positions and adding to 89 existing holdings. Its largest new stake was Barclays: 2,681,214 shares worth $21.4M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Microsoft, an estimated $17.9M trimmed.
- Advisory Research's largest Q4 2020 buy was Barclays: 2,681,214 shares worth $21.4M.
- Advisory Research added most to British American Tobacco in Q4 2020, an estimated $15.3M increase.
- Advisory Research's biggest Q4 2020 reduction was Microsoft, cutting an estimated $17.9M.
- Advisory Research fully exited eBay in Q4 2020, selling an estimated $10.7M.
- Advisory Research's ten largest holdings make up 21% of its $1.36B portfolio in Q4 2020.
- Advisory Research opened 69 new positions and closed 57 in Q4 2020.
- Advisory Research's portfolio value rose 33% quarter-over-quarter to $1.36B.
Based on Advisory Research's 13F filing for Q4 2020, filed 12 Feb 2021.